“…The result? Pain. ARK Innovation posted a negative 11.6% total return this year so far, says Morningstar Direct. That makes it the fourth worst-performing actively traded U.S. diversified ETF this year. Even behind rival funds from T. Rowe Price (TROW) and Fidelity.… Continue Reading…